Lurosetron (INN) is a serotonin 5-HT3 receptor antagonist.[1]
Synthesis
References
- ^ Prakash SP, Cable KM, Correa ID, Fellows L, Montgomery S, Newman JJ, Waterhouse L, Wells GN, Sutherland DR (1995). “Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists”. Journal of Labelled Compounds and Radiopharmaceuticals. 36 (10): 993–1007. doi:10.1002/jlcr.2580361011.
- ^ EP 0353983, Coates, Ian Harold; Oxford, Alexander William & North, Peter Charles et al., published 1990-02-07, assigned to Glaxo Group Ltd.